Carl Zeiss Meditec AG (CZMWY)
USD 48.09
(-1.39%)
USD 48.09
(-1.39%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 520.22 Million EUR | 35.92% |
| 2022 | 382.74 Million EUR | 33.65% |
| 2021 | 286.37 Million EUR | 0.01% |
| 2020 | 286.36 Million EUR | 6.72% |
| 2019 | 268.32 Million EUR | 8.15% |
| 2018 | 248.09 Million EUR | 5.89% |
| 2017 | 234.3 Million EUR | 12.48% |
| 2016 | 208.3 Million EUR | 9.98% |
| 2015 | 189.41 Million EUR | 9.87% |
| 2014 | 172.4 Million EUR | 16.12% |
| 2013 | 148.46 Million EUR | 3.81% |
| 2012 | 143.01 Million EUR | 7.04% |
| 2011 | 133.6 Million EUR | 12.07% |
| 2010 | 119.21 Million EUR | 20.35% |
| 2009 | 99.05 Million EUR | -16.97% |
| 2008 | 119.3 Million EUR | 17.93% |
| 2007 | 101.16 Million EUR | 79.55% |
| 2006 | 56.34 Million EUR | 4.27% |
| 2005 | 54.03 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 555.28 Million EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q4 | 520.22 Million EUR | 0.0% |
| 2023 FY | 520.22 Million EUR | 35.92% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q2 | 441.4 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q4 | 382.74 Million EUR | 0.0% |
| 2022 FY | 382.74 Million EUR | 33.65% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q2 | 328.86 Million EUR | 0.0% |
| 2021 Q4 | 286.37 Million EUR | 0.0% |
| 2021 FY | 286.37 Million EUR | 0.01% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 274.07 Million EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 286.36 Million EUR | 6.72% |
| 2020 Q4 | 286.36 Million EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 Q2 | 317.43 Million EUR | 0.0% |
| 2019 Q2 | 270.7 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 Q4 | 268.32 Million EUR | 0.0% |
| 2019 FY | 268.32 Million EUR | 8.15% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 FY | 248.09 Million EUR | 5.89% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 248.09 Million EUR | 0.0% |
| 2018 Q2 | 247.47 Million EUR | 0.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 Q2 | 229.41 Million EUR | 0.0% |
| 2017 FY | 234.3 Million EUR | 12.48% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q4 | 234.3 Million EUR | 0.0% |
| 2016 FY | 208.3 Million EUR | 9.98% |
| 2016 Q4 | 208.3 Million EUR | -3.54% |
| 2016 Q3 | 215.94 Million EUR | 7.09% |
| 2016 Q2 | 201.65 Million EUR | -1.41% |
| 2016 Q1 | 204.53 Million EUR | 7.98% |
| 2015 Q1 | 185.28 Million EUR | 7.47% |
| 2015 FY | 189.41 Million EUR | 9.87% |
| 2015 Q2 | 205.41 Million EUR | 10.86% |
| 2015 Q4 | 189.41 Million EUR | -9.15% |
| 2015 Q3 | 208.48 Million EUR | 1.49% |
| 2014 FY | 172.4 Million EUR | 16.12% |
| 2014 Q4 | 172.4 Million EUR | -0.92% |
| 2014 Q2 | 161.55 Million EUR | -0.41% |
| 2014 Q1 | 162.22 Million EUR | 9.27% |
| 2014 Q3 | 174 Million EUR | 7.7% |
| 2013 Q1 | 145.99 Million EUR | 2.09% |
| 2013 FY | 148.46 Million EUR | 3.81% |
| 2013 Q3 | 157.25 Million EUR | 4.07% |
| 2013 Q2 | 151.11 Million EUR | 3.5% |
| 2013 Q4 | 148.46 Million EUR | -5.59% |
| 2012 FY | 143.01 Million EUR | 7.04% |
| 2012 Q1 | 141.78 Million EUR | 6.12% |
| 2012 Q4 | 143.01 Million EUR | -6.56% |
| 2012 Q3 | 153.05 Million EUR | 8.99% |
| 2012 Q2 | 140.43 Million EUR | -0.95% |
| 2011 Q4 | 133.6 Million EUR | -3.66% |
| 2011 Q1 | 126.45 Million EUR | 6.08% |
| 2011 Q2 | 132.32 Million EUR | 4.64% |
| 2011 Q3 | 138.68 Million EUR | 4.8% |
| 2011 FY | 133.6 Million EUR | 12.07% |
| 2010 Q4 | 119.21 Million EUR | -4.36% |
| 2010 FY | 119.21 Million EUR | 20.35% |
| 2010 Q3 | 124.64 Million EUR | 16.31% |
| 2010 Q2 | 107.17 Million EUR | 9.3% |
| 2010 Q1 | 98.04 Million EUR | -1.02% |
| 2009 Q4 | 99.05 Million EUR | 0.0% |
| 2009 FY | 99.05 Million EUR | -16.97% |
| 2008 FY | 119.3 Million EUR | 17.93% |
| 2007 FY | 101.16 Million EUR | 79.55% |
| 2006 FY | 56.34 Million EUR | 4.27% |
| 2005 FY | 54.03 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -388625.911% |
| Ansell Limited | 457.04 Million USD | -13.825% |
| Ansell Limited | 457.9 Million USD | -13.612% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -1100.462% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -1865185.048% |
| Psykey, Inc. | 49.94 Thousand USD | -1041606.047% |
| ConvaTec Group Plc | 395.54 Million USD | -31.523% |
| ConvaTec Group Plc | 396.1 Million USD | -31.338% |
| Encision Inc. | 1.4 Million USD | -36997.191% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 5597560.727% |
| LifePoint, Inc. | 2.3 Million USD | -22427.1% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -21549.105% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -117865.533% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -566091.419% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -53405.271% |
| SmileDirectClub, Inc. | 49.87 Million USD | -943.085% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -47.897% |
| SheerVision, Inc. | 339.66 Thousand USD | -153060.044% |
| United Health Products, Inc. | 33.59 Thousand USD | -1548289.785% |
| Vasamed, Inc. | 449.02 Thousand USD | -115756.472% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -6080881.882% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -161374.736% |